22nd Century Group (XXII) Reports Second Quarter 2023 Financial Results
Second Quarter 2023 Net Revenues Increased 62% to $23.4 Million Launched VLN® Sales in California,…
Logistics
QIAGEN receives FDA approval for companion diagnostic to Blueprint Medicines’ AYVAKIT® (avapritinib) in gastrointestinal stromal tumors
QIAGEN’s therascreen PDGFRA RGQ PCR kit approved in U.S. to aid in identifying patients with…
Societal CDMO to Report Financial Results for Second Quarter 2023 on August 9, 2023
Webcast Scheduled for Wednesday, August 9, 2023, at 4:30 p.m. Eastern SAN DIEGO and GAINESVILLE,…
Outlook Therapeutics® to Present at the BTIG Virtual Biotechnology Conference 2023
Live webcast fireside chat on Monday, August 7th at 1:00 PM ET ISELIN, N.J., Aug….
BioNTech Completes Acquisition of InstaDeep
Acquisition aims to strengthen BioNTech’s pioneering position in the field of AI-powered drug discovery, design…
BioNTech Completes Acquisition of InstaDeep
Acquisition aims to strengthen BioNTech’s pioneering position in the field of AI-powered drug discovery, design…
Societal CDMO Announces Expansion of Controlled Substance Manufacturing Capabilities to Address Expanding Psychedelic Drug Development Market
Company Secures Schedule 1 Controlled Substance Manufacturing License from Drug Enforcement Agency, Expands on 25…
Societal CDMO Announces Expansion of Controlled Substance Manufacturing Capabilities to Address Expanding Psychedelic Drug Development Market
Company Secures Schedule 1 Controlled Substance Manufacturing License from Drug Enforcement Agency, Expands on 25…
QIAGEN expands range of digital PCR kits and services for the biopharma industry
New partnership with Niba Labs to offer customized digital PCR (dPCR) assay design services to…
Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities
CINCINNATI, July 17, 2023 (GLOBE NEWSWIRE) — Blue Water Biotech, Inc. (“Blue Water” or the…
Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities
CINCINNATI, July 17, 2023 (GLOBE NEWSWIRE) — Blue Water Biotech, Inc. (“Blue Water” or the…
Intelligent Bio Solutions Signs South American Distribution Agreement with TSCOM for Fingerprint Drug Screening System and Secures First Order
NEW YORK, July 06, 2023 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS”…
Intelligent Bio Solutions Signs South American Distribution Agreement with TSCOM for Fingerprint Drug Screening System and Secures First Order
NEW YORK, July 06, 2023 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS”…
Mustang Bio Announces Participation in Upcoming Scientific Meetings
Management team to speak at 2nd In Vivo Engineering of Therapeutic Cells Summit and 8th…
Mustang Bio Announces Participation in Upcoming Scientific Meetings
Management team to speak at 2nd In Vivo Engineering of Therapeutic Cells Summit and 8th…
Societal CDMO Signs Master Service Agreement With CivicaScript to Provide CDMO Services
Scope of Work Spans Full Range of Services including Analytical Method Transfer, Formulation Development, Process…
Societal CDMO Signs Master Service Agreement With CivicaScript to Provide CDMO Services
Scope of Work Spans Full Range of Services including Analytical Method Transfer, Formulation Development, Process…
Intelligent Bio Solutions Receives Guidance from U.S. FDA on a Regulatory Pathway for Expansion into the United States for its Intelligent Fingerprinting Drug Screening Cartridge
Company intends to submit 510(k) pre-market notification to the FDA NEW YORK, June 28, 2023…
Intelligent Bio Solutions Receives Guidance from U.S. FDA on a Regulatory Pathway for Expansion into the United States for its Intelligent Fingerprinting Drug Screening Cartridge
Company intends to submit 510(k) pre-market notification to the FDA NEW YORK, June 28, 2023…
Avicanna Provides Corporate Update and Preliminary Q2 Results
TORONTO, June 28, 2023 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN)…